Brief: Ascelia Pharma Received Supportive Feedback From EMA On Phase 3 Program For Mangoral

Ascelia Pharma AB

07/05/2019 16:52

May 7 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * ASCELIA PHARMA RECEIVED SUPPORTIVE FEEDBACK FROM EMA ON
THE
PHASE 3 PROGRAM FOR MANGORAL®
    * ASCELIA PHARMA AB - CO WILL NOW FINALISE PREPARATIONS FOR
CLINICAL PHASE 3 STUDY AND EXPECTS TO ENROL FIRST PATIENT DURING
SECOND HALF OF 2019

Source text for Eikon:  ID:nWkr6bqhqj 
Further company coverage:  ACELP.ST 

 ((Reuters.Briefs@thomsonreuters.com;))